Stay updated on Ad26.COV2.S Vaccine Study Clinical Trial
Sign up to get notified when there's something new on the Ad26.COV2.S Vaccine Study Clinical Trial page.

Latest updates to the Ad26.COV2.S Vaccine Study Clinical Trial page
- CheckyesterdayChange DetectedThe footer now identifies ClinicalTrials.gov as revision v3.8.1 instead of v3.8.0.SummaryDifference0.0%

- Check8 days agoChange DetectedThe record now presents details of the completed Phase 3 Ad26.COV2.S COVID-19 prevention study, including its design, eligibility, outcomes, and participating locations. It also includes study results-related information, publications, record dates, and study documents.SummaryDifference100%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe ClinicalTrials.gov footer revision changes from v3.7.2 to v3.8.0; the page remains a 403 Forbidden error.SummaryDifference0.2%

- Check29 days agoChange DetectedAn NIH announcement banner about terminology changes during a federal transition appears above the blocked study record.SummaryDifference1%

- Check36 days agoChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2 on the page displaying a 403 Forbidden error.SummaryDifference0.2%

- Check43 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1 while the page continued to display a 403 error.SummaryDifference0.2%

Stay in the know with updates to Ad26.COV2.S Vaccine Study Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ad26.COV2.S Vaccine Study Clinical Trial page.